A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade

Journal of Biological Chemistry

Volumn 287, Issue 15, 2012, Pages 11942-11950

  Mediouni, Sonia ^a   Watkins, Jennifer D ^b   Pierres, Michel ^c   Bole, Angélique ^c   Loret, Erwann P ^a   Baillat, Gilbert ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR UPTAKE; CONFORMATIONAL EPITOPES; EXTRACELLULAR; HIV-1 INFECTIONS; IMMUNE SYSTEMS; INFECTED PATIENTS; PASSIVE IMMUNIZATION; THREE-DIMENSIONAL EPITOPES; TRANSACTIVATORS; UNFOLDED PROTEINS;

ANTIGENS; CLONING; MONOCLONAL ANTIBODIES;

IMMUNIZATION;

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 27A8; MONOCLONAL ANTIBODY 7G12; PROTEIN VARIANT; TAT OYI PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL TRANSPORT; CLADISTICS; CONTROLLED STUDY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNIZATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RAT; VIRUS CLASSIFICATION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; APOPTOSIS; CELL PROLIFERATION; EPITOPE MAPPING; EPITOPES; HELA CELLS; HIV-1; HUMANS; JURKAT CELLS; LYMPHOCYTES; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTIONAL ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; ORYCTOLAGUS CUNICULUS;

EID: 84859487580     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.319863     Document Type: Article

References (47)

1. Kramer, V. G., Siddappa, N. B., and Ruprecht, R. M. (2007) Passive immunization as tool to identify protective HIV-1 Env epitopes. Curr. HIV Res. 5, 642-655 (Pubitemid 351210997)
2. Wu, Y., and Marsh, J. W. (2001) Selective transcription and modulation of resting T-cell activity by preintegrated HIV DNA. Science 293, 1503-1506 (Pubitemid 32801554)
3. Wong-Staal, F., and Gallo, R. C. (1985) Human T-lymphotropic retroviruses. Nature 317, 395-403
4. Cullen, B. R. (1990) The HIV-1 Tat protein. An RNA sequence-specific processivity factor? Cell 63, 655-657
5. Gougeon, M. L. (2003) Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3, 392-404
6. Huang, L., Bosch, I., Hofmann, W., Sodroski, J., and Pardee, A. B. (1998) Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J. Virol. 72, 8952-8960 (Pubitemid 28471839)
7. Huet, T., Dazza, M. C., Brun-Vézinet, F., Roelants, G. E., and Wain-Hobson, S. (1989) A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical Western blot. AIDS 3, 707-715 (Pubitemid 20021430)
8. Opi, S., Péloponèse, J. M., Jr., Esquieu, D., Campbell, G., de Mareuil, J., Walburger, A., Solomiac, M., Grégoire, C., Bouveret, E., Yirrell, D. L., and Loret, E. P. (2002) Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants. J. Biol. Chem. 277, 35915-35919
9. Watkins, J. D., Lancelot, S., Campbell, G. R., Esquieu, D., de Mareuil, J., Opi, S., Annappa, S., Salles, J. P., and Loret, E. P. (2006) Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology 3, 8-17
10. Péloponèse, J. M., Jr., Collette, Y., Grégoire, C., Bailly, C., Campèse, D., Meurs, E. F., Olive, D., and Loret, E. P. (1999) Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J. Biol. Chem. 274, 11473-11478
11. Campbell, G. R., Watkins, J. D., Esquieu, D., Pasquier, E., Loret, E. P., and Spector, S. A. (2005) TheCterminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells. J. Biol. Chem. 280, 38376-38382 (Pubitemid 43853734)
12. Fuller, S. A., Takahashi, M., and Hurrell, J. G. R. (1991) in Current Protocols in Molecular Biology, pp. 11.01-11.11.5, John Wiley and Sons, New York
13. Hardy, F., Djavadi-Ohaniance, L., and Goldberg, M. E. (1997) Measurement of antibody/antigen association rate constants in solution by a method based on the enzyme-linked immunosorbent assay. J. Immunol. Methods 200, 155-159 (Pubitemid 27035697)
14. Harakeh, S., Diab-Assaf, M., Niedzwiecki, A., Khalife, J., Abu-El-Ardat, K., and Rath, M. (2006) Apoptosis induction by Epican Forte in HTLV-1 positive and negative malignant T-cells. Leuk. Res. 30, 869-881 (Pubitemid 43816700)
15. Mediouni, S., Baillat, G., Darque, A., Ravaux, I., and Loret, E. (2011) HIV-1 infected patients have antibodies recognizing folded Tat. Infect. Disord. Drug Targets 11, 57-63
16. Siddappa, N. B., Venkatramanan, M., Venkatesh, P., Janki, M. V., Jayasuryan, N., Desai, A., Ravi, V., and Ranga, U. (2006) Transactivation and signaling functions of Tat are not correlated. Biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology 3, 53-73
17. de Mareuil, J., Carre, M., Barbier, P., Campbell, G. R., Lancelot, S., Opi, S., Esquieu, D., Watkins, J. D., Prevot, C., Braguer, D., Peyrot, V., and Loret, E. P. (2005) HIV-1 Tat protein enhances microtubule polymerization. Retrovirology 2, 5-15
18. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P., and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287 (Pubitemid 23002988)
19. Ma, M., and Nath, A. (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71, 2495-2499 (Pubitemid 27078635)
20. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., and Katinger, H. (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70, 1100-1108 (Pubitemid 26029030)
21. Zwick, M. B., Parren, P. W., Saphire, E. O., Church, S., Wang, M., Scott, J. K., Dawson, P. E., Wilson, I. A., and Burton, D. R. (2003) Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. J. Virol. 77, 5863-5876 (Pubitemid 36538979)
22. Conley, A. J., Gorny, M. K., Kessler, J. A., 2nd, Boots, L. J., Ossorio-Castro, M., Koenig, S., Lineberger, D. W., Emini, E. A., Williams, C., and Zolla- Pazner, S. (1994) Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-452D. J. Virol. 68, 6994-7000 (Pubitemid 24328749)
23. Moulard, M., Phogat, S. K., Shu, Y., Labrijn, A. F., Xiao, X., Binley, J. M., Zhang, M. Y., Sidorov, I. A., Broder, C. C., Robinson, J., Parren, P. W., Burton, D. R., and Dimitrov, D. S. (2002) Broadly cross-reactive HIV-1- neutralizing human monoclonal Fab selected for binding to gp120-CD4- CCR5 complexes. Proc. Natl. Acad. Sci. U.S.A. 99, 6913-6918 (Pubitemid 34526232)
24. Zhang, M. Y., Shu, Y., Phogat, S., Xiao, X., Cham, F., Bouma, P., Choudhary, A., Feng, Y. R., Sanz, I., Rybak, S., Broder, C. C., Quinnan, G. V., Evans, T., and Dimitrov, D. S. (2003) Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. J. Immunol. Methods 283, 17-25 (Pubitemid 37501056)
25. Zhang, M. Y., Xiao, X., Sidorov, I. A., Choudhry, V., Cham, F., Zhang, P. F., Bouma, P., Zwick, M., Choudhary, A., Montefiori, D. C., Broder, C. C., Burton, D. R., Quinnan, G. V., Jr., and Dimitrov, D. S. (2004) Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. J. Virol. 78, 9233-9242 (Pubitemid 39096533)
26. Tudor, D., and Bomsel, M. (2011) The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner. AIDS 25, 751-759
27. Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., and Katinger, H. (2001) A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 17, 1757-1765 (Pubitemid 34114213)
28. Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., and Parren, P. W. (2001) Broadly neutralizing antibodies targeted to the membrane- proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75, 10892-10905 (Pubitemid 33034579)
29. Manrique, A., Rusert, P., Joos, B., Fischer, M., Kuster, H., Leemann, C., Niederöst, B., Weber, R., Stiegler, G., Katinger, H., Günthard, H. F., and Trkola, A. (2007) In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10. J. Virol. 81, 8793-8808 (Pubitemid 47242852)
30. Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., Weber, R., Stiegler, G., Vcelar, B., Katinger, H., Aceto, L., and Günthard, H. F. (2005) Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat. Med 11, 615-622 (Pubitemid 40868301)
31. Chen, W., and Dimitrov, D. S. (2011) Monoclonal antibody-based candidate therapeutics against HIV Type 1. AIDS Res. Hum. Retroviruses. 10.1089/aid.2011.0226
32. Wu, X., Yang, Z. Y., Li, Y., Hogerkorp, C. M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., Longo, N. S., McKee, K., O'Dell, S., Louder, M. K., Wycuff, D. L., Feng, Y., Nason, M., Doria-Rose, N., Connors, M., Kwong, P. D., Roederer, M., Wyatt, R. T., Nabel, G. J., and Mascola, J. R. (2010) Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856-861
33. Corti, D., Langedijk, J. P., Hinz, A., Seaman, M. S., Vanzetta, F., Fernandez- Rodriguez, B. M., Silacci, C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S., Willems, B., Zekveld, M. J., Dreja, H., O'Sullivan, E., Pade, C., Orkin, C., Jeffs, S. A., Montefiori, D. C., Davis, D., Weissenhorn, W., McKnight, A., Heeney, J. L., Sallusto, F., Sattentau, Q. J., Weiss, R. A., and Lanzavecchia, A. (2010) Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoSONE 5, e08805
34. Walker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., Zwick, M. B., Phogat, S. K., Poignard, P., and Burton, D. R. (2010) A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoSPathog. 6, e1001028
35. Steinaa, L., Sørensen, A. M., Nielsen, J. O., and Hansen, J. E. (1994) Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch. Virol. 139, 263-271
36. Re, M. C., Furlini, G., Vignoli, M., Ramazzotti, E., Roderigo, G., De Rosa, V., Zauli, G., Lolli, S., Capitani, S., and La Placa, M. (1995) Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10, 408-416
37. Valvatne, H., Szilvay, A. M., and Helland, D. E. (1996) A monoclonal antibody defines a novel HIV type 1 Tat domain involved in trans-cellular trans-activation. AIDS Res. Hum. Retroviruses 12, 611-619 (Pubitemid 26120293)
38. Rodman, T. C., Lutton, J. D., Jiang, S., Al-Kouatly, H. B., and Winston, R. (2001) Circulating natural IgM antibodies and their corresponding human cord blood cell-derived Mabs specifically combat the Tat protein of HIV. Exp. Hematol. 29, 1004-1009 (Pubitemid 32725798)
39. Moreau, E., Hoebeke, J., Zagury, D., Muller, S., and Desgranges, C. (2004) Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen. J. Virol. 78, 3792-3796 (Pubitemid 38568316)
40. Watkins, J. D., Campbell, G. R., Halimi, H., and Loret, E. P. (2008) Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. Retrovirology 5, 83-93
41. Shojania, S., and O'Neil, J. D. (2006) HIV-1 Tat is a natively unfolded protein. The solution conformation and dynamics of reduced HIV-1 Tat- (1-72) by NMR spectroscopy. J. Biol. Chem. 281, 8347-8356 (Pubitemid 43847935)
42. Campbell, G. R., and Loret, E. P. (2009) What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology 6, 50-63
43. Lamaze, C., Dujeancourt, A., Baba, T., Lo, C. G., Benmerah, A., and Dautry- Varsat, A. (2001) Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell 7, 661-671 (Pubitemid 32706357)
44. Mann, D. A., and Frankel, A. D. (1991) Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733-1739 (Pubitemid 21905640)
45. Saitoh, A., Hsia, K., Fenton, T., Powell, C. A., Christopherson, C., Fletcher, C. V., Starr, S. E., and Spector, S. A. (2002) Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children. J. Infect. Dis. 185, 1409-1416 (Pubitemid 34507962)
46. Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., Quinn, T. C., Chaisson, R. E., Rosenberg, E., Walker, B., Gange, S., Gallant, J., and Siliciano, R. F. (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med 5, 512-517 (Pubitemid 29220209)
47. Kitabwalla, M., Ferrantelli, F., Wang, T., Chalmers, A., Katinger, H., Stiegler, G., Cavacini, L. A., Chou, T. C., and Ruprecht, R. M. (2003) Primary African HIV clade A and D isolates. Effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B. AIDS Res. Hum. Retroviruses 19, 125-131 (Pubitemid 36308050)